Effect of treating allergic rhinitis with corticosteroids in patients with mild-to-moderate persistent asthma

Chest

Volumn 128, Issue 5, 2005, Pages 3140-3147

  Stelmach, Rafael ^a,b   Nunes, Maria Do Patrocínio T ^a   Ribeiro, Marcos ^a   Cukier, Alberto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Allergy; Asthma; Bronchial reactivity; Inhaled corticosteroids; Rhinitis

Indexed keywords

BECLOMETASONE DIPROPIONATE; CORTICOSTEROID;

ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; ASTHMA; BRAZIL; BRONCHUS HYPERREACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; HIGH RISK PATIENT; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 28144450084     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.5.3140     Document Type: Article

References (40)

1. Grossman J. One airway, one disease. Chest 1997; 111(suppl): S11-S16
2. Bousqet J, Vignola AM, Demoly P. Links between rhinitis and asthma. Allergy 2003; 58:691-706
3. Simons FER. Allergic rhinobronchitis: the asthma-allergic rhinitis link. J Allergy Clin Immunol 1999; 104:534-540
4. Chanez P, Vignola MV, Vic P, et al. Comparison between nasal and bronchial inflammation in asthmatic and control subjects. Am J Respir Crit Care Med 1999; 159:588-595
5. Passalaqua G, Ciprandi G, Canonica GW. The nose-lung interaction in allergic rhinitis and asthma: united airways disease. Curr Opin Allergy Clin Immunol 2001; 1:7-13
6. Fuhlbrigge AL, Adams RJ. The effect of treatment of allergic rhinitis on asthma morbidity, including emergency departments visits. Curr Opin Allergy Clin Immunol 2003; 3:29-32
7. Guerra S, Sherrill D, Martinez F, et al. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 2002; 109:419-425
8. S Linneberg A, Nielsen NH, Frelund L, et al. The link between allergic rhinitis and allergic asthma: a prospective population-based study. The Copenhagen Allergy Study. Allergy 2002; 57:1048-1052
9. Bousquet J, Cauwenberge PV, Khaltaev N. Allergic rhinitis and its impact on asthma: ARIA Workshop Report. J Allergy Clin Immunol 2001; 108:S1-S334
10. Global Initiative for Asthma. Available at: www.ginasthma. com. Accessed October 18, 2005
11. Pauwels R. Influence of treatment on the nose and/or the lungs. Clin Exp Allergy 1998; 28:S37-S40
12. Reed CE, Marcoux JP, Welsh PW. Effects of topical nasal treatment on asthma symptoms. J Allergy Clin Immunol 1988; 81:1042-1047
13. Watson WTA, Becker AB, Simons FE. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. J Allergy Clin Immunol 1993; 92:97-101
14. Pedersen W, Hjuler I, Bisgaard H, et al. Nasal inhalation of budesonide from a spacer in children with perennial rhinitis and asthma. Allergy 1998; 53:383-387
15. Thio BJ, Slingerland GL, Fredriks AM, et al. Influence of intranasal steroids during the grass pollen season on bronchial responsiveness in children and young adults with asthma and hay fever. Thorax 2000; 55:826-832
16. National Heart Lung and Blood Institute. Guidelines for the diagnosis and management of asthma: highlights of the Expert Panel Report 2, 1997. Bethesda, MD: National Institutes of Health, 1997; Publication 97-4051A
17. American Thoracic Society. Standardization of spirometry. Am J Respir Crit Care Med 1995; 152:1107-1136
18. International Consensus Report on the diagnosis and management of rhinitis. International Rhinitis Management Working Group. Allergy 1994; 49:S1-S34
19. Cockcroft DW, Killian DN, Mellon JJA, et al. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977; 7:235-243
20. Timm NH. Multivariate analysis with applications in educations and psychology. Belmont, CA: Brooks/Cole, 1975; 444-471
21. Diggle PJ, Liang K, Zeger SL. Analysis of longitudinal data. Oxford, UK: Clarendon Press, 1994
22. Agresti A. Categorical data analysis. New York, NY: John Wiley & Sons, 1990
23. Aubier M, Levy J, Clerici C, et al. Different effects of nasal and bronchial glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitis. Am Rev Respir Dis 1992; 146:122-126
24. Djukanovic R, Wilson JW, Britten KM, et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 1992; 145:669-674
25. Woolcock AJ, Jenkins C. Aerosol and oral corticosteroids in the treatment of asthma. Agents Actions 1988; 23(suppl):261-268
26. Armitage JM, Lam KS, Wilkinson I, et al. JM. Investigation of the tendency to wheeze in pollen-sensitive patients. Clin Exp Allergy 1992; 22:916-922
27. Joyce DP, Jackevicius C, Chapman KR, et al. The placebo effect in asthma drug therapy trials: a meta-analysis. J Asthma 2000; 37:303-318
28. Greiff L, Anderson M, Svenson C, et al. Effect of orally inhaled budesonide in seasonal allergic rhinitis. Eur Respir J 1998; 11:1268-1274
29. Bucca C, Rolla G, Brussino L, et al. Are asthma-like symptoms due to bronchial or extrathoracic airway dysfunction? Lancet 1995; 346:791-795
30. Bucca C, Rolla G, Scappaticci E. Extrathoracic and intrathoracic airway responsiveness in sinusitis. J Allergy Clin Immunol 1995; 95:52-59
31. Denburg J, Sehmi R, Saito H, et al. Systemic aspects of allergic disease: bone marrow. J Allergy Clin Immunol 2000; 106:S242-S246
32. Braunstahl GJ, Overbeek SE, Fokkens WJ, et al. Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med 2001; 164:858-865
33. Braunstahl GJ, Overbeek SE, Kleinjan K, et al. Nasal allergen provocation induces adhesion molecules expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 2001; 107:469-476
34. Corren J, Adinoff AD, Irvin CG. Changes in bronchial responsiveness following nasal provocation with allergen. J Allergy Clin Immunol 1992; 89:611-618
35. Foresi A, Pelucchi A, Gherson G, et al. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. J Allergy Clin Immunol 1996; 98:274-282
36. Crimi E, Spavanello A, Neri M, et al. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med 1998; 157:4-9
37. Haley K, Drazen JM. Inflammation and airway function in asthma: what you see is not necessarily what you get. Am J Respir Crit Care Med 1998; 157:1-3
38. Crystal-Peters J, Neslusan C, Crown WH, et al. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol 2002; 109:57-62
39. Adams RJ, Fuhlbrigge AL, Finkelstein JA, et al. Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol 2002; 109:636-642
40. Tokias A. Systemic cross-talk between the lung and the nose. Am J Respir Crit Care Med 2001; 164:726-727